News | November 28, 2024
Granules' net zero commitment approved by SBTi
In the near term, the company targets a 42% reduction in absolute Scope 1 and 2 emissions and Scope 3 emissions by FY2030
In the near term, the company targets a 42% reduction in absolute Scope 1 and 2 emissions and Scope 3 emissions by FY2030
CPHI & PMEC India Expo 2024 to bring over 50,000 industry professionals and 2,000 exhibitors under one roof
The product will be manufactured at Lupin’s Somerset facility in the US
Bumetanide Injection USP (RLD Bumex) had an estimated annual sale of USD 20 million in the US
With 6 operation hubs and 18 offices across North America, Europe, and Asia, Indegene’s client base includes the world’s top 20 biopharma companies
This product will be manufactured at Lupin’s Nagpur facility in India
The inspection concluded with the issuance of Form 483 with four observations which are procedural in nature
Lupin's R&D teams are working on products with a near-zero global warming potential propellant
Prednisolone Acetate Ophthalmic Suspension is the first generic version of Pred Forte
Subscribe To Our Newsletter & Stay Updated
